↓ Skip to main content
What is this page? Embed badge

The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma

Overview of attention for article published in Journal of Hematology & Oncology, January 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
53 Mendeley
Summary Patents Dimensions citations
So far, Altmetric has seen 1 patent that references this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.